Focal Therapy in Prostate Cancer PDF
Preview Focal Therapy in Prostate Cancer
P1:SFK/UKS P2:SFK Color:1C BLBK390-FM BLBK390-Ahmed October5,2011 11:46 Trim:244mmX172mm Focal Therapy in Prostate Cancer i P1:SFK/UKS P2:SFK Color:1C BLBK390-FM BLBK390-Ahmed October5,2011 11:46 Trim:244mmX172mm Focal Therapy in Prostate Cancer EDITED BY Hashim U Ahmed MRCS, BM, BCh, BA(Hons) DivisionofSurgeryandInterventionalScience UniversityCollegeLondon London,UK Manit Arya FRCS, FRCS(Urol) DepartmentofUrology UniversityCollegeLondon London,UK Peter Carroll DepartmentofUrology UniversityofCalifornia SanFrancisco,CA,USA Mark Emberton DivisionofSurgeryandInterventionalScience UniversityCollegeLondon London,UK A John Wiley & Sons, Ltd., Publication iii P1:SFK/UKS P2:SFK Color:1C BLBK390-FM BLBK390-Ahmed October5,2011 11:46 Trim:244mmX172mm Thiseditionfirstpublished2012(cid:1)C 2012byBlackwellPublishingLtd. BlackwellPublishingwasacquiredbyJohnWiley&SonsinFebruary2007.Blackwell’spublishing programhasbeenmergedwithWiley’sglobalScientific,TechnicalandMedicalbusinesstoform Wiley-Blackwell. Registeredoffice: JohnWiley&Sons,Ltd,TheAtrium,SouthernGate,Chichester,WestSussex, PO198SQ,UK Editorialoffices: 9600GarsingtonRoad,Oxford,OX42DQ,UK TheAtrium,SouthernGate,Chichester,WestSussex,PO198SQ,UK 111RiverStreet,Hoboken,NJ07030-5774,USA Fordetailsofourglobaleditorialoffices,forcustomerservicesandforinformationabouthowto applyforpermissiontoreusethecopyrightmaterialinthisbookpleaseseeourwebsiteat www.wiley.com/wiley-blackwell Therightoftheauthortobeidentifiedastheauthorofthisworkhasbeenassertedinaccordance withtheUKCopyright,DesignsandPatentsAct1988. Allrightsreserved.Nopartofthispublicationmaybereproduced,storedinaretrievalsystem,or transmitted,inanyformorbyanymeans,electronic,mechanical,photocopying,recordingor otherwise,exceptaspermittedbytheUKCopyright,DesignsandPatentsAct1988,withoutthe priorpermissionofthepublisher. Designationsusedbycompaniestodistinguishtheirproductsareoftenclaimedastrademarks.All brandnamesandproductnamesusedinthisbookaretradenames,servicemarks,trademarksor registeredtrademarksoftheirrespectiveowners.Thepublisherisnotassociatedwithanyproductor vendormentionedinthisbook.Thispublicationisdesignedtoprovideaccurateandauthoritative informationinregardtothesubjectmattercovered.Itissoldontheunderstandingthatthe publisherisnotengagedinrenderingprofessionalservices.Ifprofessionaladviceorotherexpert assistanceisrequired,theservicesofacompetentprofessionalshouldbesought. Thecontentsofthisworkareintendedtofurthergeneralscientificresearch,understanding,and discussiononlyandarenotintendedandshouldnotberelieduponasrecommendingorpromoting aspecificmethod,diagnosis,ortreatmentbyphysiciansforanyparticularpatient.Thepublisherand theauthormakenorepresentationsorwarrantieswithrespecttotheaccuracyorcompletenessof thecontentsofthisworkandspecificallydisclaimallwarranties,includingwithoutlimitationany impliedwarrantiesoffitnessforaparticularpurpose.Inviewofongoingresearch,equipment modifications,changesingovernmentalregulations,andtheconstantflowofinformationrelating totheuseofmedicines,equipment,anddevices,thereaderisurgedtoreviewandevaluatethe informationprovidedinthepackageinsertorinstructionsforeachmedicine,equipment,ordevice for,amongotherthings,anychangesintheinstructionsorindicationofusageandforadded warningsandprecautions.Readersshouldconsultwithaspecialistwhereappropriate.Thefactthat anorganizationorWebsiteisreferredtointhisworkasacitationand/orapotentialsourceof furtherinformationdoesnotmeanthattheauthororthepublisherendorsestheinformationthe organizationorWebsitemayprovideorrecommendationsitmaymake.Further,readersshouldbe awarethatInternetWebsiteslistedinthisworkmayhavechangedordisappearedbetweenwhen thisworkwaswrittenandwhenitisread.Nowarrantymaybecreatedorextendedbyany promotionalstatementsforthiswork.Neitherthepublishernortheauthorshallbeliableforany damagesarisingherefrom. LibraryofCongressCataloging-in-PublicationData Focaltherapyinprostatecancer/editedbyHashimU.Ahmed...[etal.]. p.;cm. Includesbibliographicalreferencesandindex. ISBN-13:978-1-4051-9649-9(hardcover:alk.paper) ISBN-10:1-4051-9649-1(hardcover:alk.paper) 1. Prostate–Cancer–Surgery.2. Cancer–Diagnosis.I. Ahmed,HashimUddin. [DNLM:1. ProstaticNeoplasms–surgery.2. AblationTechniques.3. NeoplasmStaging.WJ762] RC280.P7F632012 616.99’463–dc23 2011015318 AcataloguerecordforthisbookisavailablefromtheBritishLibrary. Thisbookispublishedinthefollowingelectronicformats:ePDF9781444346862;WileyOnline Library9781444346893;ePub9781444346879;Mobi9781444346886 (cid:1) Setin10/13ptMeridienbyAptaraR Inc.,NewDelhi,India 1 2012 iv P1:SFK/UKS P2:SFK Color:1C BLBK390-FM BLBK390-Ahmed October7,2011 8:32 Trim:244mmX172mm Contents ContributorList,vii Preface,xi SectionI IstherearoleforFocalTherapyinLocalised ProstateCancer?,1 1 TheRationaleforFocalTherapyofProstateCancer,3 ColeDavis,MatthewCooperberg,andPeterR.Carroll 2 FactorsThatAffectPatients’ChoiceofTreatment,11 DebFeldman-StewartandMichaelD.Brundage 3 HistologicalTrendsandtheIndexLesioninLocalized ProstateCancer,17 VladimirMouraviev,ThomasWheeler,andThomasJ.Polascik 4 SelectionCriteriaforProstateCancerFocalTherapy,29 RajatK.Jain,TimothyK.Ito,andSamirS.Taneja SectionII Howcanweaccuratelylocatecancerwithin thegland?,37 5 LocalisationofCancerwithintheGland:BiopsyStrategies,39 WinstonEBarzellandRodrigoPinochet 6 LocalisationofCancerwithintheGland:UltrasoundImaging,47 UlrichScheipers 7 LocalizationofCancerwithintheProstate:Dynamic Contrast-EnhancedMRI,55 PhilippePuech,AnwarPadhani,LaurentLemaitre, NacimBetrouni,PierreColin,andArnauldVillers 8 LocalizationofCancerwithintheGland:Diffusion-Weighted MagneticResonanceImagingoftheProstate,66 SophieFRiches,NinaTunariu,andNanditaMdeSouza 9 ThefutureofMolecularandBiomolecularImagingin ProstateCancer,75 MichaelS.GeeandMukeshG.Harisinghani v P1:SFK/UKS P2:SFK Color:1C BLBK390-FM BLBK390-Ahmed October7,2011 8:32 Trim:244mmX172mm vi Contents SectionIII Howcanwecreatediscretetissuenecrosis?,85 10 EnergiesforFocalAblation:Cryoablation,87 JohnF.Ward 11 FocalSalvageCryoablationinRecurrentProstateCancer,98 KatsutoShinohara 12 High-IntensityFocusedUltrasound,106 HashimUddinAhmedandMarkEmberton 13 EnergiesforFocalAblation:PhotodynamicTherapy,114 CarolineM.Moore,NimalanArumainayagamandMarkEmberton 14 FocalTherapyforProstateCancerUsingRadiation,126 IrvingKaplan,ElizabethGenegaandNeilRofsky 15 ImageRegistrationandFusionforImage-GuidedFocalAblation,132 DeanBarrattandDavidHawkes SectionIV Howcanwedeterminethesuccessof FocalTherapy?,143 16 DeterminingSuccessofFocalTherapy:Biochemical andBiopsyStrategies,145 AlBarqawi,PaulMaroni,andDavidCrawford 17 DeterminingSuccessofFocalTherapy:Imaging,153 AlexKirkhamandClareAllen 18 EvaluatingFocalTherapy:FuturePerspectives,170 HashimUddinAhmedandMarkEmberton Index,179 Colourplatesectioncanbefoundfacingpage116 P1:SFK/UKS P2:SFK Color:1C BLBK390-Contri BLBK390-Ahmed September8,2011 7:18 Trim:244mmX172mm Contributor List HashimU.AhmedMRCS,BM,BCh, NacimBetrouniPhD BA(Hons) INSERM MRCClinicianScientistinUro-Oncology UniversityofLilleNorddeFrance ClinicalLecturerinUrology Lille,France DivisionofSurgeryandInterventionalSciences UniversityCollegeLondon MichaelD.BrundageMSc, London,UK FRCPC,MD Professor ClareAllenMD,FRCR,BM,BCh DepartmentofOncologyandDepartmentof ConsultantRadiologist CommunityHealthandEpidemiology DepartmentofRadiology Queen’sUniversity;and UniversityCollegeLondonHospitalsNHS RadiationOncologist FoundationTrust CancerCentreofSoutheasternOntario London,UK Kingston,ON,Canada NimalanArumainayagamMD Director SpecialistRegistrarinUrology DivisionofCancerCareandEpidemiology DivisionofSurgeryandInterventionalSciences CancerResearchInstitute UniversityCollegeLondon Queen’sUniversity London,UK Kingston,ON,Canada DeanC.BarrattPhD PeterR.CarrollMD,MPH SeniorLecturerinMedicalImageComputing ProfessorandChair UCLCentreforMedicalImageComputing DepartmentofUrology UniversityCollegeLondon UCSFHelenDillerFamilyComprehensive London,UK CancerCenter UniversityofCalifornia,SanFrancisco AlB.BarqawiMD,FRCS SanFrancisco,CA,USA AssociateProfessorofSurgery/Urology DirectorofProstateCancerFellowshipProgram PierreColinMD DivisionofUrology ChefdecliniqueAssistant UniversityofColoradoDenverSchoolof DepartmentofUrology Medicine CHRULille,UniversityofLilleNorddeFrance Aurora,CO,USA Lille,France WinstonE.BarzellMD, MatthewCooperbergMD,MPH FRCS,FACS AssistantProfessor ClinicalAssistantProfessor DepartmentofUrology FSUCollegeofMedicine UCSFHelenDillerFamilyComprehensive UrologyTreatmentCenter CancerCenter Sarasota,FL,USA UniversityofCalifornia,SanFrancisco SanFrancisco,CA,USA vii P1:SFK/UKS P2:SFK Color:1C BLBK390-Contri BLBK390-Ahmed September8,2011 7:18 Trim:244mmX172mm viii ContributorList E.DavidCrawfordMD MichaelS.GeeMD,PhD ProfessorofSurgery/Urology/Radiation AssistantRadiologist Oncology AbdominalImagingandInterventional HeadUrologicOncology Radiology E.DavidCrawfordEndowedChairinUrologic MassachusettsGeneralHospital Oncology HarvardMedicalSchool UniversityofColorado,Denver Boston,MA,USA Aurora,CO,USA AssistantProfessor ColeDavisMD TheUniversityofTexas ClinicalOncologyFellow MDAndersonCancerCenter DepartmentofUrology Houston,TX,USA UCSFHelenDillerFamilyComprehensive CancerCenter DavidJ.HawkesPhD,CPhys, UniversityofCalifornia,SanFrancisco FMedSci,FREng,FInstP,FIPEM SanFrancisco,CA,USA DirectoroftheUCLCentreforMedicalImage Computing NanditaM.deSouzaBSc,MBBS,MD, UniversityCollegeLondon FRCP,FRCR London,UK ProfessorofTranslationalImaging InstituteofCancerResearchandRoyalMarsden MukeshG.HarisinghaniMD Hospital DirectorofAbdominalMRI London,UK AssociateProfessorofRadiology DepartmentofRadiology MarkEmbertonFRCS(Urol),FRCS, HarvardUniversity MD,MBBS,BSc Boston,MA,USA ProfessorofInterventionalOncologyand HonoraryConsultantUrologicalSurgeon TimothyK.Ito DivisionofSurgeryandInterventionalScience ResidentinUrology UniversityCollegeLondon DivisionofUrologicOncology London,UK DepartmentofUrology NewYorkUniversityLangoneMedicalCenter NIHRUCL/UCHComprehensiveBiomedical NewYork,NY,USA ResearchCentre London,UK RajatK.Jain ResidentinUrology DebFeldman-StewartPhD NewYorkUniversityLangoneMedicalCenter CognitivePsychologist SchoolofMedicine DivisionofCancerCareandEpidemiology NewYork,NY,USA CancerResearchInstitute Queen’sUniversity IrvingKaplanMD Kingston,ON,Canada AssistantProfessorRadiationOncology HarvardMedicalSchool Professor Boston,MA,USA DepartmentofOncology Queen’sUniversity BethIsraelDeaconessMedicalCenter Kingston,ON,Canada Boston,MA,USA ElizabethM.GenegaMD AlexKirkhamBM,BCh,FRCS, Staffpathologist FRCR,MD BethIsraelDeaconessMedicalCenter ConsultantRadiologist Boston,MA,USA DepartmentofRadiology AssistantProfessor UniversityCollegeLondonHospitalsNHS HarvardMedicalSchool FoundationTrust Boston,MA,USA London,UK P1:SFK/UKS P2:SFK Color:1C BLBK390-Contri BLBK390-Ahmed September8,2011 7:18 Trim:244mmX172mm ContributorList ix LaurentLemaitreMD,PhD PhilippePuechMD,PhD Professor AssociateprofessorofRadiology DepartmentofRadiology CHRULille UniversityofLilleNorddeFrance UniversityofLilleNorddeFrance Lille,France Lille,France PaulD.MaroniMD INSERM AssistantProfessor UniversityofLilleNorddeFrance DivisionofUrology Lille,France DepartmentofSurgery UniversityofColoradoSchoolofMedicine NeilRofskyMD Aurora,CO,USA ProfessorofRadiology DepartmentofRadiology CarolineM.MooreMD,MRCS(Ed) BethIsraelDeaconessMedicalCenter ClinicalLecturerinUrology Boston,MA,USA UniversityCollegeLondonandUniversity CollegeLondonHopsitalsNHSTrust SophieF.RichesMPhysMsc London,UK ClinicalPhysicist InstituteofCancerResearchandRoyalMarsden VladimirMouravievMD Hospital ClinicalFellowInstructor London,UK UrologyDivision DepartmentofSurgery UlrichScheipersPhD UniversityofCincinnati TomTecImagingSystemsGmbH CollegeofMedicine Unterschleissheim,Germany Cincinnati,OH Ruhr-UniversityBochum,Bochum,Germany KatsutoShinoharaMD AnwarPadhaniMBBS HelenDillerFamilyChairinClinicalUrology ConsultantinRadiology Professor,DepartmentofUrologyandRadiation PaulStricklandImagingCentre Oncology MountVernonCancerCentre UniversityofCalifornia,SanFrancisco Northwood,Middlesex,UK SanFrancisco,CA,USA RodrigoPinochetMD SamirS.TanejaMD UrologicOncologyFellow JamesM.NeissaandJanetRihaNeissa MemorialSloan-KetteringCancerCenter AssociateProfessorofUrologicOncology NewYork,NY,USA Director,DivisionofUrologicOncology DepartmentofUrology AssociateInstructor GUProgramLeader,NewYorkUniversity DepartmentofUrology CancerInstitute PontificiaUniversidadCatolicadeChile NewYorkUniversityLangoneMedicalCenter Santiago,Chile NewYork,NY,USA LouisL.PistersMD Chief ProfessorofUrology UrologySection TheUniversityofTexasMDAndersonCancer VeteransAdministration Center NewYorkHarborHealthcareSystem Houston,TX,USA (Manhattancampus) NewYork,NYUSA ThomasJ.PolascikMD,FACS DirectorofUrologicOncology NinaTunariuMD DukeCancerInstitute SpecialistRegistrarinRadiology DukeUniversityMedicalCenter InstituteofCancerResearchandRoyalMarsden Durham,NC,USA Hospital London,UK P1:SFK/UKS P2:SFK Color:1C BLBK390-Contri BLBK390-Ahmed September8,2011 7:18 Trim:244mmX172mm x ContributorList ArnauldVillersMD,PhD TheUniversityofTexas ProfessorinUrology MDAndersonCancerCenter DepartmentofUrology Houston,TX,USA CHRULille,UniversityofLilleNorddeFrance Lille,France ThomasM.WheelerMD HarlanJ.SpjutProfessorandChair JohnF.WardMD,FACS DepartmentofPathologyandImmunology AssistantProfessor BaylorCollegeofMedicine DepartmentofUrology Houston,TX,USA P1:SFK/UKS P2:SFK Color:1C BLBK390-Preface BLBK390-Ahmed August14,2011 8:37 Trim:244mmX172mm Preface to the first edition The diagnostic and therapeutic landscape of prostate cancer is one of the mostexcitingareasofmedicalresearchinourmodernage.Veryfewcon- ditions or diseases have caused as much controversy and debate in the medical and popular literature. The manner in which we currently diag- noseandtreatprostatecancerseemstoleadtoeverincreasingcosttothe individualpatient,tohisfamily,andtohealthcaresystemsingeneral,but with great uncertainty over the benefits. The entire pathway has come into question, based as it is on inherent inaccuracy and lack of precision in locating, targeting, and treating the malignant tumor. Almost all other solid organ cancers rely on visualizing the cancer, sampling it accurately, anddeliveringtherapyonlytothatareawhichrequiresit. Focal therapy in prostate cancer supports a similar, albeit belated, paradigmshift.Suchachangereliesonaccurateimaging,accuratebiopsy, and accurate destruction of the cancer while minimizing collateral dam- age and preserving as much normal tissue as possible. What are the ben- efits? We may have an isoeffective treatment that carries less harm to theindividualmaninamorecost-effectivewaythatbenefitssociety.The challenges are tremendous—locating cancers in a walnut-sized organ is noteasy—ablatingareastomillimeteraccuracyandensuringtheremain- der of the tissue does not develop new cancers which progress into life- threatening disease. This book is written by international experts at the forefrontofimagingandfocaltherapyofprostatecancerandwillprovide thereaderwithacomprehensivescientificapproachtotheaspirationsand challengesoffocaltherapy. HashimU.Ahmed ManitArya PeterCarroll MarkEmberton November2011 xi
Description:The list of books you might like
